Clinical Trials in Houston

Showing 17701-17720 of 17,885 trials

Study of Nitazoxanide in the Treatment of Clostridium Difficile Colitis

NCT00417872

The primary objective is to demonstrate non-inferiority of nitazoxanide administered 500 mg b.i.d compared to metronidazole administered 250 mg q.i.d. in resolving symptoms of Clotridium difficile colitis after seven days of treatment. Secondary objectives are to provide information on the times from first dose to last unformed stool and resolution of symptoms of colitis, the sustained response rates for the different tratment groups and the effect of treatment on Clostridium difficile toxin enzyme immunoassay/culture results during hospitalization.

Clostridium Difficile

Romark Laboratories L.C.114 participantsStarted Jan 2004

St. Petersburg, Florida, United States • Marietta, Georgia, United States • Columbus, Ohio, United States +4 more locations

COMPLETEDPhase 2< 1 mile

A Study to Evaluate the Single-Agent Lenalidomide in Subjects With Recurrent Non-Small-Cell Lung Cancer

NCT00179686

Subjects who qualify will receive single agent lenalidomide once daily on days 1-21 of 28 day cycles. Subjects will continue until disease progression is documented.

Non-Small Cell Lung Cancer

Celgene Corporation40 participantsStarted Mar 2005

Birmingham, Alabama, United States • Chicago, Illinois, United States • Chicago, Illinois, United States +3 more locations

COMPLETEDPhase 3< 1 mile

Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure.

NCT00048425

The purpose of this study is to evaluate the efficacy of a 24-hour infusion of levosimendan compared with placebo in the treatment of decompensated chronic heart failure.

Heart Failure, Congestive

Abbott600 participantsStarted Sep 2002

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Birmingham, Alabama, United States +163 more locations

Study of Nitazoxanide in the Treatment of Clostridium Difficile Colitis

A Study to Evaluate the Single-Agent Lenalidomide in Subjects With Recurrent Non-Small-Cell Lung Cancer

Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure.

Find Trials by Condition in Houston

Autologous T Cell Immunotherapy for Chronic Lymphocytic Leukemia (CLL) Patients

Safety Study to Evaluate Intracranial Pressure During High Frequency Chest Wall Oscillation

A Phase 2, Randomized, Open-Label Study Of Single Agent CI-1033 In Patients With Advanced Non-Small Cell Lung Cancer

Study for Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)

A Trial Of Gemcitabine Plus Paclitaxel And Gemcitabine Plus Docetaxel In Metastatic Breast Cancer

Six Month Clinical Trial Assessing Efficacy And Safety Of Inhaled Insulin In Type 2 Diabetes

Clinical Investigation of the SelectSecure Pacing Lead

Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer

Study Evaluating the Safety & Efficacy of DVS-223 SR for Relief of Vasomotor Symptoms Associated With Menopause

Chemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Amonafide in Combination With Cytarabine in Secondary AML

An Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects

To Evaluate the Long-Term Safety of Pregabalin in Refractory Partial Epilepsy.

Effectiveness of Duloxetine in the Treatment of Stress Urinary Incontinence(Uncontrolled Leakage of Urine)

HepeX-B in Post Hepatic Allografts for Treatment of End Stage Liver Disease Due to Hepatitis B Infection

SP01A: The Study of an Oral Entry Inhibitor in Treatment-Experienced HIV Patients

Bipolar Depression Study: Bipolar Depression Assessment Study on Treatment Response